| |
HW (n = 77)
|
OV (n = 82)
|
OB (n = 83)
|
P
|
|---|
|
TC, mg/dL
|
143 (32.1)
|
140 (34.3)
|
142 (39.8)
|
0.864
|
|
LDL-C, mg/dL
|
86 (33.5)
|
85 (35.6)
|
89 (40.1)
|
0.800
|
|
HDL-C, mg/dL
|
42 (13.5)
|
37 (13.3)*
|
35 (12.6)*
|
<0.001
|
|
TG, mg/dL
|
75 (29.7)
|
87 (49.7)
|
91 (45.1)*
|
0.07
|
|
TG/HDL-C
|
1.90 (0.86)
|
2.69 (1.98)*
|
3.07 (2.24)*
|
0.001
|
|
TC/HDL-C
|
3.67 (1.39)
|
4.02 (1.72)
|
4.59 (2.16)*
|
0.021
|
|
LDL-C/HDL-C
|
1.81 (0.52)
|
1.90 (0.90)
|
1.79 (0.71)
|
0.051
|
|
Non HDL-C
|
100.9 (33.9)
|
102.6 (38.3)
|
107.1 (43.2)
|
0,575
|
|
Apo AI, mg/dL
|
120.9 (18.0)
|
113.7 (19.6)
|
109.1 (21.2)*
|
0.001
|
|
Apo B, mg/dL
|
62.8 (10.6)
|
65.2 (15.8)
|
65.2 (17.5)
|
0.533
|
|
Apo B/Apo AI
|
0.53 (0.12)
|
0.60 (0.15)
|
0.61 (0.16)*
|
0.003
|
|
LDL-C/ApoB
|
1.38 (0.4)
|
1.33 (0.48)
|
1.37 (0.53)
|
0.810
|
|
HDL-C/ApoA
|
0.35 (0.09)
|
0.33 (0.12)
|
0.32 (0.10)
|
0.122
|
|
LDL (−), mg/mL
|
8.9 (5)
|
10.8 (4.9)
|
10.5 (5.2) *
|
0.042
|
|
Anti LDL(−), mg/mL
|
8.5 (2.6)
|
7.5 (2.7)*
|
7.2 (3.0)*
|
0.010
|
|
HDL size, nm
|
10.8 (2.7)
|
10.8 (2.3)
|
10.9 (3.2)
|
0.638
|
|
Glucose, mg/dL
|
79.3 (12.8)
|
78.0 (12.5)
|
82.0 (13.2)
|
0.130
|
|
Insulin, uU/mL
|
15.3 (7.1)
|
19.8 (8.2)*
|
25.9 (14.5)*;**
|
<0.001
|
|
HOMA-IR
|
3.0 (1.5)
|
3.9 (2.0)*
|
5.3 (3.1)*;**
|
<0.001
|
- HW, healthy weight; OV, overweight; OB, obese; BMI, Body Mass Index; WC, waist circumference, HOMA-IR, homeostasis model assessment of insulin resistance; TC, total cholesterol; LDL, low density lipoprotein; HDL, high density lipoprotein.
- Results were described as mean (standard deviation). *P < 0.05 vs HW group. **P < 0.05 vs OV group.
